Cargando…
Drug-induced diabetes and hepatoxicity in COVID-19 patients
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124584/ https://www.ncbi.nlm.nih.gov/pubmed/35649305 http://dx.doi.org/10.1016/j.dsx.2022.102514 |
_version_ | 1784711769727434752 |
---|---|
author | Ghosh, Rajdeep Basak, Ullash Ghosh, Debasish Sarkar, Joy |
author_facet | Ghosh, Rajdeep Basak, Ullash Ghosh, Debasish Sarkar, Joy |
author_sort | Ghosh, Rajdeep |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9124584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Diabetes India. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91245842022-05-23 Drug-induced diabetes and hepatoxicity in COVID-19 patients Ghosh, Rajdeep Basak, Ullash Ghosh, Debasish Sarkar, Joy Diabetes Metab Syndr Letter to the Editor Diabetes India. Published by Elsevier Ltd. 2022-06 2022-05-22 /pmc/articles/PMC9124584/ /pubmed/35649305 http://dx.doi.org/10.1016/j.dsx.2022.102514 Text en © 2022 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Ghosh, Rajdeep Basak, Ullash Ghosh, Debasish Sarkar, Joy Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title | Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title_full | Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title_fullStr | Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title_full_unstemmed | Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title_short | Drug-induced diabetes and hepatoxicity in COVID-19 patients |
title_sort | drug-induced diabetes and hepatoxicity in covid-19 patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124584/ https://www.ncbi.nlm.nih.gov/pubmed/35649305 http://dx.doi.org/10.1016/j.dsx.2022.102514 |
work_keys_str_mv | AT ghoshrajdeep druginduceddiabetesandhepatoxicityincovid19patients AT basakullash druginduceddiabetesandhepatoxicityincovid19patients AT ghoshdebasish druginduceddiabetesandhepatoxicityincovid19patients AT sarkarjoy druginduceddiabetesandhepatoxicityincovid19patients |